Delivery Order SPE2DB25D3306-SPE2DB25FUCJX
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $9,085.44 to AmerisourceBergen Drug Corp for 120 tablets of Yonsa 125 mg, a pharmaceutical product supporting military healthcare needs. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 2, 2025, and represents a child contract under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA. The place of performance is AmerisourceBergen's corporate office location...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract worth $13,172.88 to AmerisourceBergen Drug Corp, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of 4563956683 - YONSA 125 MG TABLET 120S, a specialty pharmaceutical product, with a period of performance through April 3, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) worth up to...
- This is a $4,542.74 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 120 tablets of the medication YONSA 125 MG with a completion date of June 10, 2025. The contract is not set aside and was competed openly. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The $2,195.48 order is for the supply of YONSA 125 MG TABLET 120S, a pharmaceutical product, with a completion date of February 29, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The $4,390.96 contract is for the supply of 4563557510 YONSA 125 MG TABLET 120S, a specialty pharmaceutical product. The contract has a completion date of February 27, 2024 and was awarded on February 5, 2024. This delivery order is issued under Amerisourcebergen Drug Corp's...
- The Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order contract worth $17,563.84 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4565098308 - YONSA 125 MG TABLET 120S. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that AmerisourceBergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of YONSA (abiraterone acetate) 125 mg tablets in a quantity of 120 units, valued at $2,271.36. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 26, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The $2,195.48 firm-fixed-price contract is for the delivery of 4,565,965,358 units of YONSA 125 MG Tablet 120S, a pharmaceutical product. The contract has an ultimate completion date of October 21, 2024. AmerisourceBergen is a major pharmaceutical distributor that supplies a wide range of medical products and drugs to various government agencies and healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $2,271.36 to AmerisourceBergen Drug Corp for 120 tablets of Yonsa 125 mg, a pharmaceutical product for medical supply needs. This is an unset-aside, competitively awarded delivery order issued under a firm fixed price arrangement with an ultimate completion date of August 25, 2025. The award leverages AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion master vehicle...
- This is a $2,195.48 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of the pharmaceutical product YONSA 125 MG TABLET 120S. The contract has a period of performance through September 9, 2024 and does not have a set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, was awarded this delivery order as part of its larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
- SPE2DB25D3306Indefinite Delivery Contract
- SPE2DB25D3306-SPE2DB25FUCJXDelivery Order
The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $2,271.36 for 120 tablets of YONSA 125 mg on July 29, 2025, with an ultimate completion date of August 19, 2025. This firm fixed-price, competitively awarded contract required no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through comprehensive pharmaceutical and medical supply deliveries. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The parent IDC functions as a global pharmaceutical support vehicle enabling the company to supply a broad range of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support military healthcare programs worldwide. The contract structure demonstrates AmerisourceBergen Drug Corp's established capability to meet federal medical supply requirements through open competition and supports DLA's strategic pharmaceutical procurement for military beneficiaries and government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 7/29/25 |